Peak Processing Receives Maximum Five-Year Health Canada Licence Renewal to September 2031

Shwetambri Chauhan

11 November 2026 12:32 PM AEDT

Peak Processing Receives Maximum Five-Year Health Canada Licence Renewal to September 2031

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Peak Processing Limited (ASX:PKP), a manufacturer of THC-infused beverages, has received a five-year renewal of its standard processing and sensory licence from Health Canada for its Oldcastle, Ontario facility, extending the licence to September 2031 — the maximum term Health Canada grants.

Key Points

Health Canada has renewed Peak Processing's Oldcastle, Ontario processing licence for five years, expiring September 2031 — the maximum term available
Previous renewals granted to Peak had each been for one year
Q4 FY26 production reached a record 1,610,908 beverage units, up 61% quarter-on-quarter
On-time-in-full (OTIF) delivery remained above 97% in Q1 FY27, compared with 53% in June 2025
355ml standard can capability and THC beverage shots were added under the existing licence

Health Canada Licence Renewal Details

Health Canada has renewed the standard processing and sensory licence for Peak Processing's Oldcastle, Ontario facility for a five-year term expiring in September 2031. The company disclosed this is the maximum term Health Canada grants. Peak's previous renewals had each been for one year. In Canada's regulated cannabis market, licence holders must maintain quality assurance systems, facility security, personnel security clearances, ongoing regulatory reporting and site inspections. Renewals are assessed against how well the licence holder controls its operations and complies with the Cannabis Act and Cannabis Regulations. Peak remains subject to the ongoing requirements of the Cannabis Act and Cannabis Regulations throughout the licence term.

Operational Performance During Licence Period

The renewal follows a period of operational activity at Peak's Canadian facility. Q4 FY26 production rose 61% quarter-on-quarter to a record 1,610,908 beverage units. OTIF delivery remained above 97% in Q1 FY27, compared with 53% in June 2025, according to Quarterly Reports released on 30 October 2026. During the same period, Peak added 355ml standard can capability and began producing THC beverage shots under its existing licence, broadening the product formats available to brand partners from its Oldcastle facility. The company stated that maintaining compliance becomes more demanding as volumes, product formats and customer numbers grow.

Removal of Annual Renewal Cycle

According to the filing, the five-year term removes the annual renewal cycle, which the company said reduces administrative burden and regulatory risk. The extended term is also described as supporting longer-term manufacturing agreements with customers and longer-horizon operational planning across the Canadian platform. Managing Director and CEO Barry Katzman said in the filing: "Moving from one-year renewals to the maximum five-year term is an important milestone for Peak. Health Canada's focus is control and compliance, and that becomes harder to maintain as an operation grows in scale and complexity." The Board of Peak Processing Limited authorised the announcement to be lodged with the ASX.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.